Nucleic Acids Research, 2002, Vol. 30, No. 22 4910-4917
© 2002 Oxford University Press
Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases
1 Institute of Biological Chemistry, Academia Sinica, Taipei, 115 Taiwan, 2 Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA, 3 Biology Department, Brookhaven National Laboratory, Upton, NY 11973, USA and 4 Institute of Biochemical Sciences, National Taiwan University, Taipei, 106 Taiwan
*To whom correspondence should be addressed at Institute of Biological Chemistry, Academia Sinica, Nankang, Taipei, 115 Taiwan. Tel: +886 2 27881981; Fax: +886 2 27882043; Email: ahjwang{at}gate.sinica.edu.tw
The potent anticancer drug actinomycin D (ActD) acts by binding to DNA GpC sequences, thereby interfering with essential biological processes including replication, transcription and topoisomerase. Certain neurological diseases are correlated with expansion of (CTG)n trinucleotide sequences, which contain many contiguous GpC sites separated by a single base pair. In order to characterize the binding of ActD to CTG triplet repeat sequences, we carried out heat denaturation and CD analyses, which showed that adjacent GpC sequences flanking a T:T mismatch are preferred ActD-binding sites, and that ActD binding results in a conformational transition to A-type structure. The structural basis of the strong binding of ActD to neighboring GpC sites flanking a T:T mismatch was provided by the crystal structure of ActD bound to ATGCTGCAT, which contains a CTG triplet sequence. Binding of two ActD molecules to GCTGC causes a kink in the DNA helix. In addition, using a synthetic self-priming DNA model, 5'-(CAG)4(CTG)16-3', we observed that ActD can trap the cruciform or duplexes of (CTG)n and interfere with the expansion process of CTG triplet repeats as shown by gel electrophoretic expansion assay. Our results may provide the possible biological consequence of ActD bound to CTG triplet repeat sequences.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Walter, G. Warnecke, R. Bowater, W. Deppert, and E. Kim Tumor Suppressor p53 Binds with High Affinity to CTG{middle dot}CAG Trinucleotide Repeats and Induces Topological Alterations in Mismatched Duplexes J. Biol. Chem., December 30, 2005; 280(52): 42497 - 42507. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Hou and A. H.-J. Wang Mithramycin forms a stable dimeric complex by chelating with Fe(II): DNA-interacting characteristics, cellular permeation and cytotoxicity Nucleic Acids Res., March 1, 2005; 33(4): 1352 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Hou, H. Robinson, Y.-G. Gao, and A. H.-J. Wang Crystal structure of the [Mg2+-(chromomycin A3)2]-d(TTGGCCAA)2 complex reveals GGCC binding specificity of the drug dimer chelated by a metal ion Nucleic Acids Res., April 23, 2004; 32(7): 2214 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Chou, K.-H. Chin, and A. H.-J. Wang Unusual DNA duplex and hairpin motifs Nucleic Acids Res., May 15, 2003; 31(10): 2461 - 2474. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Chin, F.-M. Chen, and S.-H. Chou Solution structure of the ActD-5'-CCGTT3GTGG-3' complex: drug interaction with tandem G{middle dot}T mismatches and hairpin loop backbone Nucleic Acids Res., May 15, 2003; 31(10): 2622 - 2629. [Abstract] [Full Text] [PDF] |
||||

